These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 5747129)

  • 1. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of antigenicity of inactivated measles vaccine on guinea pigs.
    Drevo M; Mares I; Závadová H
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(4):389-96. PubMed ID: 5752126
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study on antigenicity of live and inactivated measles vaccine.
    Arakawa S; Kaneko T
    Jpn J Exp Med; 1966 Feb; 36(1):37-47. PubMed ID: 5297255
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenicity of UV-inactivated measles virus.
    Zahorska R; Mazur N; Korbecki M
    Zentralbl Bakteriol Orig A; 1978 Jun; 240(4):424-30. PubMed ID: 696055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEASLES VACCINATION. II. ANTIBODY TITERS 8 TO 9 MONTHS AFTER VACCINATION WITH AN INACTIVATED VACCINE.
    NORRBY E; CARLSTROEM G; LAGERCRANTZ R; GARD S
    Acta Paediatr (Stockh); 1964 Nov; 53():533-40. PubMed ID: 14225879
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on measles in Thailand. IV. Persistence of measles antibody in the absence of natural virus two years after vaccination by the "KL" method.
    Sangkawibha N; Tsuchida P; Bukkavesa S; Ostanonda P; Ueda S
    Biken J; 1971 Jun; 14(2):149-54. PubMed ID: 5122205
    [No Abstract]   [Full Text] [Related]  

  • 9. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.
    GARD S; CARLSTROEM G; LAGERCRANTZ R; NORRBY E
    Arch Gesamte Virusforsch; 1965; 16():315-23. PubMed ID: 14322885
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 11. Soluble antigen of measles virus.
    Numazaki Y; Karzon DT
    J Immunol; 1966 Oct; 97(4):470-6. PubMed ID: 5957255
    [No Abstract]   [Full Text] [Related]  

  • 12. Materials on measles pathogenesis and vaccinal process.
    Sergiev PG; Shroit IG; Chelysheva KM; Smirnova EV; Kuksova MI; Shevtsova ZV; Levenshtam MA; Chernomordik AE; Kozlyuk AS; Stromova GI; Manjko TG; Yefimov EE; Shamrayeva SA; Voskresenskaya GS
    Acta Virol; 1966 Sep; 10(5):430-9. PubMed ID: 4380362
    [No Abstract]   [Full Text] [Related]  

  • 13. A serological study of children vaccinated against measles.
    Strauss J; Zdrazílek J; Svandová E; Sejda J; Helcl J
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(4):468-81. PubMed ID: 5391988
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical-laboratory experiences with combined dried live measles-smallpox vaccine.
    Weibel RE; Stokes J; Buynak EB; Hilleman MR; Grunmeier PW
    Pediatrics; 1966 Jun; 37(6):913-20. PubMed ID: 5933940
    [No Abstract]   [Full Text] [Related]  

  • 16. [Specific prophylaxis in measles. I. Preparation of a vaccine with modified live virus (strain M60-5 Huang)].
    Cajal N; Cepleanu M; Sorodoc Y
    Stud Cercet Inframicrobiol; 1966; 17(5):371-6. PubMed ID: 5964005
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mumps-antibody formation in guinea pigs following a single virus application. Evaluation of live mumps-virus vaccine].
    Gladthe H; Abel C
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(2):202-7. PubMed ID: 5064723
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical immunoserological study of combined innoculation of inactivated and live measles vaccines].
    Yamazaki Y
    Nihon Shonika Gakkai Zasshi; 1969 May; 73(5):644-55. PubMed ID: 5817193
    [No Abstract]   [Full Text] [Related]  

  • 19. Observation of the protective effect of live measles vaccines in the first year after vaccination.
    Sejda J; Helcl J; Strauss J
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(3):288-95. PubMed ID: 4161911
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
    Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.